Optimal management of older patients with chronic lymphocytic leukemia: Some facts and principles guiding therapeutic choices-Reference-Cited by-同舟云学术

Optimal management of older patients with chronic lymphocytic leukemia: Some facts and principles guiding therapeutic choices

Published:2012-01 Issue:1 Volume:26 Page:15-23
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Tadmor Tamar,Polliack Aaron

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference77 articles.

1. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial;Hallek;Lancet,2010

2. SEER cancer statistics review, 1975–2008;Howlader,2010

3. Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century;Brenner;Blood,2008

4. Improving survival in patients with chronic lymphocytic leukemia (1980–2008): the Hospital Clínic of Barcelona experience;Abrisqueta;Blood,2009

5. Presenting features and outcome of chronic lymphocytic leukemia patients diagnosed at age 80years or more. An ICLLSG study;Bairey;Ann Hematol: Springer Berlin/Heidelberg,2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of venetoclax and rituximab in the treatment of concurrent acute myeloid leukemia and untreated chronic lymphocytic leukemia: A case report and literature review;Oncology Letters;2024-06-25

2. Updates from the American Society of Hematology 2019 Annual Meeting: Practice-Changing Studies in Treatment-Naïve Chronic Lymphocytic Leukemia;Current Oncology;2020-05-01

3. Spontaneous Regression of Clinically Indolent Lymphomas Revealed by 18F-FDG PET/CT;Clinical Nuclear Medicine;2019-04

4. Impact of age and comorbidities on the efficacy of FC and FCR regimens in chronic lymphocytic leukemia;Annals of Hematology;2018-06-26

5. Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study;Leukemia;2018-04-27